US Patent Issued to Sarepta Therapeutics on April 29 for "Treatment methods for muscular dystrophy" (Massachusetts Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,630, issued on April 29, was assigned to Sarepta Therapeutics Inc. (Cambridge, Mass.).

"Treatment methods for muscular dystrophy" was invented by Huadong Sun (Cambridge, Mass.), Lilly East (Cambridge, Mass.), Jon Tinsley (Cambridge, Mass.) and Jake Elkins (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "New dosing regimens for treating muscular dystrophy in a patient suffering from Duchenne muscular dystrophy (DMD) with an antisense oligonucleotide conjugate that causes skipping of an exon in the human dystrophin gene are described. Also described is a method of treating a patient with an antisense oligomer CPP conjugate and a magnesi...